Inotiv (NOTVQ) Cash from Restructuring (2022 - 2023)
Inotiv's (NOTVQ) quarterly Cash from Restructuring came in at $1.3 million in Q3 2023, down 64.46% YoY from $3.7 million in Q3 2022, and up 1.0% on a QoQ basis from $1.3 million in Q2 2023.
Inotiv (NOTVQ) Cash from Restructuring (2022 - 2023) Analysis & Trends
Inotiv (NOTVQ) has 2 years of Cash from Restructuring data on file, last reported at $1.3 million in Q3 2023.
- Quarterly Cash from Restructuring fell 64.46% year-over-year to $1.3 million in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $11.2 million (changed N/A YoY) and the FY2023 annual result came in at $4.6 million, down 45.99% from the prior year.
- Cash from Restructuring improved to $1.3 million in Q3 2023, from $1.3 million in the prior quarter.
- In the past five years, Cash from Restructuring ranged from a high of $4.9 million in Q2 2022 to a low of $1.3 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Inotiv | 348,881.46 | -14.83 Mn | 111.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 1.32 Mn |
| Jun 30, 2023 | 1.30 Mn |
| Sep 30, 2022 | 3.70 Mn |
| Jun 30, 2022 | 4.86 Mn |